Celgene Cellular Therapeutics broke ground yesterday on a facility that will harvest stem cells from placentas and umbilical cords, thus sidestepping the moral morass produced by harvesting stem cells from embryos or fetal tissue, according to an article
in today's Monroe (La.) News Star
. NIH has the next move: where do these stem cell lines fit within the President's research-funding policies announced two years ago this month?